Flower


Lupin and Lilly partner to improve access to diabetes treatment

by The Welthi Bureau |

lupin and lilly partner to improve access to diabetes treatment
 Image used for representational purpose only

Mumbai, October 1, 2018: Pharma Major Lupin Limited ("Lupin") and Eli Lilly and Company (India) Pvt. Ltd. ("Lilly India"), have announced the expansion of their business partnership aimed at widening access to innovative diabetes medicines in India. Under the new partnership, Lupin will distribute and market Lilly's Aplevant® (dulaglutide), a once-weekly injection for type 2 diabetes treatment.

 

Aplevant® (dulaglutide) is a once-weekly injectable solution for adults with type 2 diabetes mellitus. Lupin expects to make Aplevant® available in India in October 2018.

 

This announcement builds on the Lupin and Lilly India business partnership initiated in 2011 to expand the promotion and distribution of Lilly's diabetes portfolio in India where Lupin has a large network.

 

Rajeev Sibal, President – India Region Formulations, Lupin said, "Our long-standing partnership with Lilly has enabled us to emerge as a strong contender in the diabetes treatment arena. Lupin is the fastest growing company in the Indian diabetes market and is now ranked as the third largest company in the Anti-diabetes market in India on a MATbasis as of August 2018*. With this new partnership, we are expanding our diabetes portfolio to include a once-weekly diabetes treatment, and improving access to innovative medications for better diabetic care in India. We are delighted to partner with Lilly India and hope to continue building our product pipeline through strategic tie-ups for innovative healthcare solutions for patients and healthcare practitioners in India."

 

Luca Visini, Managing Director, Lilly India said, "Lilly's heritage in diabetes spans from the first commercial release of insulin in 1923 to leading scientific discoveries of today. Since 1923, we have continuously strived to innovate to meet the diverse needs of people living with diabetes offering a wide portfolio of treatments among which include the first biosynthetic 'human' insulin with recombinant DNA technology, the first rapid insulin analog, and a once weekly non-insulin injection for type 2 diabetes. Building on this strong heritage and legacy in the diabetes field, and our commitment to making life better for all those living with diabetes in India, we are thrilled to work with Lupin to make our innovative therapies and solutions available to a large number of healthcare professionals and patients who need them."


 Disclaimer: Welthi.com does not guarantee any specific results as a result of the procedures mentioned here, and the results may vary from person to person. Read more
Wadia Hospital opened its first Outreach OPD in Nashik for children with congenital heart disease

Wadia Hospital opened its first Outreach OPD in ...

Wadia Hospitals are heritage legendary leading ins...
KIMS Organize a National Nursing Conference

KIMS Organize a National Nursing Conference

Krishna Institute of Medical Sciences (KIMS) in as...
Why the Monsoons are Critical for Kidneys

Why the Monsoons are Critical for Kidneys

The Kidneys play a vital role in the functioning o...
Busting the Myths of Breastfeeding

Busting the Myths of Breastfeeding

The first week of August is celebrated in over 120...
Get rid of unwanted Dandruff easily

Get rid of unwanted Dandruff easily

Everybody experiences dandruff at some point in th...
EMPOWER PARENTS ENABLE BREASTFEEDING World Breastfeeding Week (1st to 7th August 2019)

EMPOWER PARENTS ENABLE BREASTFEEDING World ...

Breastfeeding is the natural and biological way of...
World Stroke Day 29th Oct 2018

World Stroke Day 29th Oct 2018

A stroke is defined as an abrupt onset of a neurol...
Hyderabad Doctors successfully perform Asia's First Transcatheter Tricuspid Valve Replacement procedure

Hyderabad Doctors successfully perform Asia's ...

Only 40 such surgeries reported around the world...
SuVitas Launches Bangalore’s First Dedicated Transition Care Facility

SuVitas Launches Bangalore’s First Dedicated ...

Catering to a need for post critical care that has...
Itermittent Fasting: The How s and Why's

Itermittent Fasting: The How s and Why's

Intermittent Fasting is the latest global fitness ...
Eyes show you the world

Eyes show you the world

With increasing rate of air pollution, the ways it...
Healthcare receives major limelight in General Budget 2018-19

Healthcare receives major limelight in General ...

Healthcare has been a core segment in every develo...